People | June 15, 2022
ADC Therapeutics appoints David Gilman as Chief Business & Strategy Officer
Gilman will be responsible for all business development and portfolio strategy efforts globally.
Gilman will be responsible for all business development and portfolio strategy efforts globally.
Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health
Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com
Dupixent peak sales ambition raised to more than €13 billion
Ritika has also extensively worked with clients such as WHO, GAVI Alliance, USAID, Gilead, Novartis, Sanofi Pasteur
The researchers are of the view that the new drug designing strategy demonstrated by them could also be adopted to treat retroviral infections.
Partnership with Duopharma Biotech covers human insulin, insulin glargine and insulin aspart, supporting diabetes care and medicine security in Malaysia
New digital platform provides global sponsors with live visibility into R&D, process development and GMP manufacturing operations, enhancing collaboration and decision-making
KIMS RENOVA Oncology Institute, in association with the Samrohana Cancer Foundation, announced the “134 Free Screening Camp Pledge”,
The filing is backed by positive Phase 3 results recently published in JAMA Neurology
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
